Cheniere Options Spike as JP Morgan Raises Target Before Q3 Print

Options positioning on LNG diverges sharply from where it sat just a week ago, even as the stock trades near its highest level of the year.

The put/call ratio jumped to 0.61 on October 23, three standard deviations above its 20-day average of 0.50. That is the most defensive options posture Cheniere has shown in months, and it arrived on the same day the stock added 4.1% to close at $298.67. The combination of a strong price move and a spike in put demand points to investors protecting gains rather than adding fresh risk into Wednesday's print. Closest peer CQP gained 3.0% on the day and 4.1% for the week, while OKE, COP and DVN each rose 2% to 4.5%, meaning LNG's weekly gain of 3.2% roughly matched the peer median of 3.4%. Cheniere is moving with the sector, not dramatically ahead of it, despite being up more than 37% year to date.

Analyst sentiment heading into the report is unambiguously positive, with the most notable move coming Thursday from JP Morgan's Jeremy Tonet, who raised his price target to $344 from $334 while keeping an Overweight rating. That puts his target well above the consensus mean of $314. The bull case centres on long-term take-or-pay contracts, the Q2 beat that lifted 2026 EBITDA guidance to the $7.9 to $8.4 billion range, and volume guidance of 53 to 54 MT. Cheniere ranks in the 96th percentile for EPS surprise across the ORTEX universe, a track record the Street is clearly leaning on. The bear case is narrower: LNG pricing uncertainty, renewal risk on contracts, and execution dependency on CCL Stage 3 and SPL Train 7 timelines. Bernstein reiterated Outperform at $283 on the same day as the JP Morgan move, sitting below the current price, a reminder that not every bullish analyst is running with the stock's recent re-rating.

Short positioning adds little tension to this setup. Short interest is 2.2% of free float, a level consistent with what was reported four days ago, and borrow availability remains exceptionally loose with more than 200 million shares available to lend against fewer than 5 million borrowed. Cost to borrow is 0.40%, up roughly 24% for the week but still negligible in absolute terms. The short score of 32 sits below the midpoint of the scale. None of this points to a community of conviction bears; the month-long 10.5% build in short shares is worth noting, but at this float level it remains a footnote.

One item on the periphery worth tracking: ORTEX puts a 40% probability on Cheniere joining the S&P 500 at the December 2026 Quarterly Review. The stock is 61.7% above the price threshold that would flip the index rule, so inclusion already appears arithmetically secure. An estimated $12.9 billion in index-tracker buying, equivalent to roughly 25 days of normal volume, would follow a confirmed addition on the December 18 trade date. That flow is mechanical and independent of Wednesday's result, but it frames why the stock's valuation, at 14x trailing earnings and 11x EV/EBITDA, may carry a structural bid beneath it regardless of what the print delivers.

The Q3 report will test whether Cheniere's 2026 guidance upgrade was conservative or has already been fully absorbed into a stock that is up more than a third this year, with options traders paying the most for protection in recent memory as the answer approaches.